ONC Live Videos of CLL Expert Doctors on current topics

[lankisterguy]

Expert Reviews Current State of CLL Treatment

onclive.cmail20.com/t/ViewE...

-

Danielle Brander, MD, highlights how recent advances are changing the field of chronic lymphocytic leukemia and what it means for patients and their oncologists.

onclive.cmail20.com/t/j-l-n...

-

Regimen Shows Potential for Reducing TLS Risk in CLL

Kerry Rogers, MD, discusses the feasibility of a new treatment for tumor lysis syndrome and what research still needs to be done with these agents in chronic lymphocytic leukemia.

onclive.cmail20.com/t/j-l-n...

-

Umbralisib Shows Promise in Relapsed/Refractory CLL

Anthony R. Mato, MD, MSCE, discusses the next steps for umbralisib and the biggest challenges still facing patients with chronic lymphocytic leukemia.

onclive.cmail20.com/t/j-l-n...

-

Addressing the Unmet Needs for the Treatment of CLL

Susan M. O’Brien, MD, discusses the unmet needs in the treatment and management of patients with chronic lymphocytic leukemia.

onclive.cmail20.com/t/j-l-n...

-

Evaluating Pharmacologic Agents in Relapsed/Refractory CLL

Michael Choi, MD, elucidates essential indications and considerations for treating relapsed/refractory chronic lymphocytic leukemia (CLL) with approved pharmacologic agents.

onclive.cmail20.com/t/j-l-n...

-

Popular on OncLive

Key Characteristics Emerging for CAR T Cell Success

An effective lymphodepletion strategy is critical to success with chimeric antigen receptor T-cell therapy, but also the choice of patients and even the cells used for CAR T cell manufacturing should be made with care.

onclive.cmail20.com/t/j-l-n...

[Mystic75]

Thank you so much!

[Name-1]

Thank you!